Home › Idiopathic Pulmonary Fibrosis › Missouri
Idiopathic Pulmonary Fibrosis clinical trials in Missouri
6 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in Missouri.
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- Hannibal Regional Healthcare System, Inc., Hannibal
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Oct 2, 2026 · NCT06951217A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Healthcare System, Inc., Hannibal
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 17, 2026 · NCT07516951Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Hannibal Regional Hospital, Hannibal
RecruitingPhase 3
Ages 40 and older · All sexes · Updated Sep 14, 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- The Lung Research Center, LLC, Chesterfield
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 4, 2026 · NCT06968845Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
- Hannibal Regional Hospital /ID# 277984, Hannibal
RecruitingPhase 2
Ages 40 and older · All sexes · Updated Sep 3, 2026 · NCT07230288Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- Washington University, St Louis
RecruitingObservational study
Ages 21 and older · All sexes · Updated Aug 12, 2026 · NCT01915511From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.